The W.H.O estimates that Ebola will take 20,000 more lives before its transmission is stopped.
Ebola Spreads to Southern Nigeria With 3 Cases Confirmed and 60 at ‘High Risk’
WHO officials warn that the epidemic is accelerating rapidly
Three
cases of Ebola have been identified in the southern Nigerian city of
Port Harcourt, the World Health Organization (WHO) says, confirming that
the disease has spread outside the capital Lagos, where five people
have died.
Officials
in Port Harcourt — a teeming city of 1.4 million in the Niger delta —
are now monitoring over 200 people, 60 of whom are considered at high
risk of having contracted the disease. It is a worrying expansion of an
epidemic that has now killed 1,900 in West Africa and defied the
attempts of under-staffed and under-funded aid teams to halt it.
WHO officials warn that the virus is not just expanding
geographically but also accelerating. Ebola has now sickened upwards of
3,500 people and in the past week alone almost 400 people have died of
the virus, said Dr. Margaret Chan, director-general of the WHO at a
press conference in Washington D.C. on Wednesday.
“This Ebola epidemic
is the longest, the most severe and the most complex we’ve ever seen,”
said Chan. Experts, she added, “have never seen anything like it.”
As the epidemic expands, resources on the ground have not, WHO
officials said. There is no room in what few hospitals there are in the
worst-hit areas; terrified medical staff have stopped showing up to
work; and in Liberia the bodies of Ebola victims are being left
unattended in the streets. Some who contract the disease are also
choosing to hide their illness—in the meantime, unwittingly infecting
those around them—rather than be turned upon by neighbors.
Meanwhile, some 150 scientists and experts convened Thursday at the
WHO’s headquarters in Geneva, Switzerland, for a two-day meeting to
review available experimental Ebola drugs and vaccines and draft testing
plans for the most promising. None of the drugs have been tested in
humans, but one of them, ZMapp, was given to two Ebola patients who
survived their illness.
On Tuesday, the U.S. Department of Health and Human Services awarded a
contract worth up to $42.3 million to ZMapp’s manufacturer,
jump-starting clinical trials and fresh production of the drug, supplies
of which are currently tapped out.
The W.H.O estimates that Ebola will take 20,000 more lives before its transmission is stopped.
No comments:
Post a Comment